neostigmine Solution for injection 0.5 mg/ml

It was established in the 1980s. Its main activity is the production of sterile and aseptic injections and solutions as well as suppositories. The fact that the large factories abolished the so-called manufacture of magistral injections. As a result, there was a shortage of these products in the market and the company tried to fill this gap. To improve the quality of the work, the company has introduced and certified the ISO 9001 quality management system. Their key goal is reflected in the development, implementation, and certification of the ISO 14001 environment-focused system of the company.